Hydroxychloroquine (International)
In the US, Hydroxychloroquine (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lichen Planopilaris, Lupus, Lyme Disease - Arthritis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome and Undifferentiated Connective Tissue Disease.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
P01BA02
CAS registry number (Chemical Abstracts Service)
0000118-42-3
Chemical Formula
C18-H26-Cl-N3-O
Molecular Weight
336
Therapeutic Categories
Antiprotozoal agent: Antimalarial
Disease-modifying antirheumatic drug, DMARD
Chemical Name
Etanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]etylamino]-
Foreign Names
- Hydroxychloroquinum (Latin)
- Hydroxychloroquin (German)
- Hydroxychloroquine (French)
- Hidroxicloroquina (Spanish)
Generic Names
- Hydroxychloroquine (OS: BAN)
- Idroxiclorochina (OS: DCIT)
- Oxychloroquine (IS)
- Win 1258-2 (IS)
- Hydroxychloroquine (PH: Ph. Eur. 9.3)
- Hydroxychloroquine Sulfate (OS: BANM, JAN)
- Hydroxychloroquine Sulfate (PH: BP 2018, Ph. Eur. 9.3, USP 41)
- Hydroxychloroquini sulfas (PH: Ph. Eur. 9.3)
Brand Names
- Axokine
Rontag, Argentina - Dimard
Metlen, Ecuador - Hidroxiplus
Perulab, Peru - Hydrocad
Cadila, India - Hydroquin
Sun Pharma, Thailand - Ilinol
Pharma Investi de Chile, Chile - Mcqs
Molekule, India - Narbon
Buxton, Argentina - Plaquenil
Concordia Pharmaceuticals, United States; Sanofi Aventis, Tunisia - Plaquinol
Sanofi-Aventis, Peru - Polireumin
Perulab, Peru - Quinilen
Royal Pharma, Chile - Quinoric
Bristol Laboratories, Cyprus; Sanolabor, Slovenia - Reumaquin
AC Farma, Peru - Supretic
Eticos, Paraguay - Zy-Q
Zydus, India - APO-Hydroxychloroquine
Apotex, Australia - Apo-Hydroxychloroquine Sulfate
Apotex, Hong Kong - Apo-Hydroxyquine
Apotex, Canada - Be-easy
Shinlon, Taiwan - Chloguin
Weidar, Taiwan - Dimard
Siegfried, Colombia - Dolquine
Rubio, Spain - Evoquin
Ivax, Argentina; Teva, Uruguay - Fen Le
ZhongXi Pharmaceutical, China - Geniquin
Genovate, Taiwan - Haloxin
Hanlim, South Korea - HCQS
IPCA, Thailand - Hequinel
Arrow Pharmaceuticals, Australia - Hidroxicloroquina Sulfato Pharma Arte
Pharma Arte, Paraguay - Hydroquine
Minapharm, Egypt; Taiwan Biotech, Taiwan - Hydroxychloroquine
Apotex, Russian Federation - Hydroxychloroquine AN
Amneal Pharma, Australia - Hydroxychloroquine GH
Generic Health, Australia - Hydroxychloroquine RBX
Ranbaxy, Australia - Hydroxychloroquine sulfate
Zentiva, United Kingdom - Hydroxychloroquine Sulfate
Hikma, United States; Ipca, United States; Mylan, United States; Sandoz, United States; Teva, United States; Watson Pharmaceutical, United States; Zydus Pharma, United States - Hydroxychloroquine Sulfate Lenis
LENIS, Slovenia - Hydroxychloroquine Sulphate P & D
P & D, Malta - Hydroxychloroquine Zentiva 200mg
Helvepharm, Switzerland - Hydroxychloroquinesulfaat CF
Centrafarm, Netherlands - Metirel
Pfizer, Uruguay; Rontag, Argentina - Mylan-Hydroxychloroquine
Mylan Pharmaceuticals, Canada - Oxiklorin
Kyung Poong, South Korea; Orion Pharma, Finland - Plaquenil
Abbott Laboratories S.A., China; Dr. Fisher Farma, Netherlands; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; First Pharma, Estonia; Lex ano, Lithuania; Sanofi, Denmark; Sanofi, Ireland; Sanofi, Japan; Sanofi, Sweden; Sanofi Aventis, China; Sanofi Belgium, Belgium; Sanofi Israel, Israel; Sanofi Malta, Malta; Sanofi Romania, Romania; Sanofi Winthrop, Kuwait; Sanofi-Aventis, Argentina; Sanofi-Aventis, Australia; Sanofi-Aventis, Canada; Sanofi-Aventis, Cyprus; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Philippines; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis Netherlands, Netherlands; Sanofi-Aventis SA, Greece; synth, Egypt - Plaquenil 200mg
Sanofi Belgium, Luxembourg; Sanofi-Aventis, Switzerland - Plaquenil-Hydroxychloroquine sulfate
Zentiva, United Kingdom - Plaquinol
Alfa Wassermann, Portugal; Sanofi Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Paraguay; Sanofi-Aventis, Venezuela; Sanofi-Aventis Farmaceutica, Brazil - Polirreumin
TRB Pharma, Argentina - Pro-Hydroxyquine
Pro Doc, Canada - Quensyl 200mg
Sanofi-Aventis Deutschland, Germany - Quinoric
Bristol Laboratories, United Kingdom; Central Procurement & Supplies Unit, Malta - Reumazine
Instituto Sanitas, Chile - Reuquinol
Apsen, Brazil
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
